The implications of the FDA bowing to conservative pressure. “Susan Wood, who headed the FDA’s Office of Women’s Health, said she was ‘very worried’ political pressure on the agency from the same conservative groups who opposed wider availability of the contraceptive could also result in a delay for a new vaccine that protects against cervical cancer . . .
. . . ‘I also worry when and if we reach an HIV vaccine’ that the same argument will be raised, she said.”
